-
Overcoming challenges of translating deep-learning models for glioblastoma: the ZGBM consortium
Authors:
Haris Shuaib,
Gareth J Barker,
Peter Sasieni,
Enrico De Vita,
Alysha Chelliah,
Roman Andrei,
Keyoumars Ashkan,
Erica Beaumont,
Lucy Brazil,
Chris Rowland-Hill,
Yue Hui Lau,
Aysha Luis,
James Powell,
Angela Swampillai,
Sean Tenant,
Stefanie C Thust,
Stephen Wastling,
Tom Young,
Thomas C Booth
Abstract:
Objective: To report imaging protocol and scheduling variance in routine care of glioblastoma patients in order to demonstrate challenges of integrating deep-learning models in glioblastoma care pathways. Additionally, to understand the most common imaging studies and image contrasts to inform the development of potentially robust deep-learning models. Methods: MR imaging data were analysed from a…
▽ More
Objective: To report imaging protocol and scheduling variance in routine care of glioblastoma patients in order to demonstrate challenges of integrating deep-learning models in glioblastoma care pathways. Additionally, to understand the most common imaging studies and image contrasts to inform the development of potentially robust deep-learning models. Methods: MR imaging data were analysed from a random sample of five patients from the prospective cohort across five participating sites of the ZGBM consortium. Reported clinical and treatment data alongside DICOM header information were analysed to understand treatment pathway imaging schedules. Results: All sites perform all structural imaging at every stage in the pathway except for the presurgical study, where in some sites only contrast-enhanced T1-weighted imaging is performed. Diffusion MRI is the most common non-structural imaging type, performed at every site. Conclusion: The imaging protocol and scheduling varies across the UK, making it challenging to develop machine-learning models that could perform robustly at other centres. Structural imaging is performed most consistently across all centres. Advances in knowledge: Successful translation of deep-learning models will likely be based on structural post-treatment imaging unless there is significant effort made to standardise non-structural or peri-operative imaging protocols and schedules.
△ Less
Submitted 7 May, 2024;
originally announced May 2024.
-
Machine Learning and Glioblastoma: Treatment Response Monitoring Biomarkers in 2021
Authors:
Thomas Booth,
Bernice Akpinar,
Andrei Roman,
Haris Shuaib,
Aysha Luis,
Alysha Chelliah,
Ayisha Al Busaidi,
Ayesha Mirchandani,
Burcu Alparslan,
Nina Mansoor,
Keyoumars Ashkan,
Sebastien Ourselin,
Marc Modat
Abstract:
The aim of the systematic review was to assess recently published studies on diagnostic test accuracy of glioblastoma treatment response monitoring biomarkers in adults, developed through machine learning (ML). Articles were searched for using MEDLINE, EMBASE, and the Cochrane Register. Included study participants were adult patients with high grade glioma who had undergone standard treatment (max…
▽ More
The aim of the systematic review was to assess recently published studies on diagnostic test accuracy of glioblastoma treatment response monitoring biomarkers in adults, developed through machine learning (ML). Articles were searched for using MEDLINE, EMBASE, and the Cochrane Register. Included study participants were adult patients with high grade glioma who had undergone standard treatment (maximal resection, radiotherapy with concomitant and adjuvant temozolomide) and subsequently underwent follow-up imaging to determine treatment response status. Risk of bias and applicability was assessed with QUADAS 2 methodology. Contingency tables were created for hold-out test sets and recall, specificity, precision, F1-score, balanced accuracy calculated. Fifteen studies were included with 1038 patients in training sets and 233 in test sets. To determine whether there was progression or a mimic, the reference standard combination of follow-up imaging and histopathology at re-operation was applied in 67% of studies. The small numbers of patient included in studies, the high risk of bias and concerns of applicability in the study designs (particularly in relation to the reference standard and patient selection due to confounding), and the low level of evidence, suggest that limited conclusions can be drawn from the data. There is likely good diagnostic performance of machine learning models that use MRI features to distinguish between progression and mimics. The diagnostic performance of ML using implicit features did not appear to be superior to ML using explicit features. There are a range of ML-based solutions poised to become treatment response monitoring biomarkers for glioblastoma. To achieve this, the development and validation of ML models require large, well-annotated datasets where the potential for confounding in the study design has been carefully considered.
△ Less
Submitted 15 April, 2021;
originally announced April 2021.
-
Enhancing Fiber Orientation Distributions using convolutional Neural Networks
Authors:
Oeslle Lucena,
Sjoerd B. Vos,
Vejay Vakharia,
John Duncan,
Keyoumars Ashkan,
Rachel Sparks,
Sebastien Ourselin
Abstract:
Accurate local fiber orientation distribution (FOD) modeling based on diffusion magnetic resonance imaging (dMRI) capable of resolving complex fiber configurations benefits from specific acquisition protocols that sample a high number of gradient directions (b-vecs), a high maximum b-value(b-vals), and multiple b-values (multi-shell). However, acquisition time is limited in a clinical setting and…
▽ More
Accurate local fiber orientation distribution (FOD) modeling based on diffusion magnetic resonance imaging (dMRI) capable of resolving complex fiber configurations benefits from specific acquisition protocols that sample a high number of gradient directions (b-vecs), a high maximum b-value(b-vals), and multiple b-values (multi-shell). However, acquisition time is limited in a clinical setting and commercial scanners may not provide such dMRI sequences. Therefore, dMRI is often acquired as single-shell (single b-value). In this work, we learn improved FODs for commercially acquired MRI. We evaluate patch-based 3D convolutional neural networks (CNNs)on their ability to regress multi-shell FOD representations from single-shell representations, where the representation is a spherical harmonics obtained from constrained spherical deconvolution (CSD) to model FODs. We evaluate U-Net and HighResNet 3D CNN architectures on data from the Human Connectome Project and an in-house dataset. We evaluate how well each CNN model can resolve local fiber orientation 1) when training and testing on datasets with the same dMRI acquisition protocol; 2) when testing on a dataset with a different dMRI acquisition protocol than used to train the CNN models; and 3) when testing on a dataset with a fewer number of gradient directions than used to train the CNN models. Our approach may enable robust CSD model estimation on single-shell dMRI acquisition protocols with few gradient directions, reducing acquisition times, facilitating translation of improved FOD estimation to time-limited clinical environments.
△ Less
Submitted 17 December, 2020; v1 submitted 12 August, 2020;
originally announced August 2020.
